Reuters logo
BRIEF-Germany's InflaRx prices Nasdaq IPO
November 8, 2017 / 6:49 AM / a month ago

BRIEF-Germany's InflaRx prices Nasdaq IPO

Nov 8 (Reuters) - Germany biopharma company InflaRx‍

* Says announces pricing of initial public offering

* Says ‍initial public offering price of $15.00 per common share, for total gross proceeds of approximately $100 million

* Says shares are scheduled to begin trading on Nasdaq Global Select Market on November 8, 2017​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below